Indian Journal of Science and Technology

Open Access Open Access  Restricted Access Subscription Access

Small Percent of Additional Abnormal Clones to Ph Chromosome in the Early Chronic Phase Detected by Large Number of Karyotype Analysis and Transformation to Blastic Crisis in Chronic Myelocytic Leukemia


Affiliations
1 Dept. of Radiobiology, Institute for Environmental Sciences, Hachazawa-2-121, Rokkasho, Takahoko, Kamikita, Aomori-039-3213, Japan
2 Hiroshima Red Cross Hospital, Senda Machi-1-9-6, Minami-ku, Hiroshima-730-8619, Japan
3 Hiroshima Atomic Bomb Relief Foundation-50-1,3 Chome Asakita-ku, Hiroshima 739-1743, Japan
 

Extensive study on Chronic Myelocytic Leukemia (CML) was performed sequentially from the time of early chronic phase to the blastic crisis (BC) phase. A large number of 80-385 metaphases were karyotyped at the time of diagnosis in 16 patients and 13 in BC phase. Three patients were BC phase at diagnosis. All the patients had small percent of clones with additional chromosome aberration in 1.3-12.4% of the observed cells in the early stages of chronic phase. The additional abnormal clones which had existed at the time of diagnosis of early chronic phase remarkably increased in the BC phase of only 5 of 10 patients examined, because 3 of the 13 patients had no additional chromosome aberrations in BC phase. New abnormal clones which were not detected at the time of diagnosis emerged into the BC phase of 5 of the 10 patients. These additional clones were not always associated with the development of the BC. In all 3 patients diagnosed at 10.6 months before developing BC, small sized clone found in early chronic phase related to main clone in BC. Then, detection of additional clones in chronic phase for early detection of BC clone can be useful at only 10.6 months before BC. However, weak correlation between frequency of additional aberrations with Ph chromosome and duration of chronic phase was found. These findings also suggested that leukemic cells harboring Ph chromosome are high chromosome instability, in which are intrinsically labile for the acquisition of various additional chromosome aberrations at any stage, which might be related with resistance to chemotherapy, and therapies of interferon α and imatinib.

Keywords

Chronic Myelocytic Leukemia, Ph Chromosome, Clonal Evolution, Large Amount Karyotype Analysis
User

  • Alimena G, Brandt L, Dallapiccola B, Mitelman F and Nilsson PG (1979) Secondary chromosome changes in chronic myeloid leukemia: relation to treatment. Cancer Genet. Cytogenet. 1, 79-85.

  • Brazma D, Grace C, Howa Apperley JF and Nacheva EP (2007) Genomic profile of chronic myelogenous leukemia: imbalances associated with disease progression. Genes Chromosome Cancer. 46, 1039-1050.

  • First Workshop on Chromosomes in Leukemia 1977 (1978) Chromosomes in Leukemia 1977 (1978) Chromosomes in Ph1-positive chronic granulocytic leukemia. Brit. J. Haematol. 39, 305-309.

  • Fleischman EW, Prigogina EL, Volkova MA, Frenkel MA, Zakhartchenko NA, Konstantinova LN, Puchkova GP and Balakirev SA (1981) Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia. Hum. Genet. 58, 285-293.

  • Ge XQ, Tanaka K, Arif M, Tazawa H, Iwato K, Kyo T, Dohy H and Kamada N (2001) Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region (M-BCR). Cancer Genet. Cytogenet. 126, 102-110.

  • Hagemeijer A, Hählen K and Abels J (1981) Cytogenetic follow-up of patients with nonlymphocytic leukemia. Acute nonlymphocytic leukemia. Cancer Genet. Cytogenet. 3, 109-124.

  • Hosoya N, Chiba S, Nannya Y, Nakazaki K, Wang L, Hangaishi A, Kurokawa M, Chiba S and Ogawa M (2006) Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization. Genes Chromosome Cancer. 45, 482-494.

  • ISCN 1995, An Iinternational System for Human Cytogenetic Nomenclature (1995). (ed. Mitelman F), also in Cytogenetics and Cell Genetics, Karger, Basel.

  • ISCN 2005, An International System for Human Cytogenetic Nomenclature (2005). (ed. Shaffer L.G & Tommerrup N), also in Cytogenetics and Genome Research, Karger, Basel.

  • Ishihara T, Sasaki M, Oshimura M, Kamada N, Yamada K, Okada M, Sakurai M, Sugiyama T, Shiraishi Y and Kohno S (1983) A summary of cytogentic studies in 534 cases of chronic myelocytic leukemia in Japan. Cancer Genet. Cytogenet. 9, 81-92.

  • Ito T, Tanaka H, Tanaka K, Ito K, Kyo T, Dohy H, Kamada N and Kimura A (2004) Insertion of a genomic fragment of chromosome 19 between BCR intron 19 and ABL intron 1a in a chronic myeloid leukemia patient with μ-BCR-ABL(e19a2) transcript. Br. J. Haematol. 12, 750-755.

  • Johansson B, Fioretos T and Mitelman F (2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta. Haematol. 107, 76-94.

  • Kamada N and Uchino H (1978) Chronological sequence in appearance of clinical and laboratory findings characteristic of chronic myelocytic leukemia. Blood. 51, 843-850.

  • Kamada N (1979) Subclassification of chronic myelocytic leukemia, In Chronic Myelocytic Leukemia, Proc. for Niigata Symposium, pp151-152, Eds. by Uchino H and Shibata A, Ishiyaku Press, Tokyo (in Japanese).

  • Kamada N, Dohy H, Okada K, Oguma N, Kuramoto A, Tanaka K and Uchino H (1981) In vivo and in vitro activity of neutrophil alkaline phosphatase in acute myekocytic leukemia with 8;21 translocation. Blood. 58, 1213-1217.

  • Kantarjian HM, Keating MJ, Talpaz M, Walters RS, Smith TL, Cork A, McCredie KB and Freirech EJ ( 1987) Chronic myelogenous leukemia in blastic crisis: analysis of 242 patients. Am. J. Med. 83, 445-554.

  • Khorashad JS, De Melo VA, Fiegler H, Gerrand G, Martin D, Apperley JF, Goldman M, Foroni L and Reid AG (2008) Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukemia at diagnosis. Leukemia. 22, 1806-1807.

  • Koptyra M, Cramer K, Slupianek A, Richardson C and Skorski T (2008) BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia. 22, 1969-1972.

  • Krulik M, Smadja N, De Gramont A, Gonzalez-Canail G, Audebert AA, Dray C, Brissaud P and Debray J (1987) Sequential karyotype study on Ph-positive chronic myelocytic leukemia. Cancer. 60, 974-979.

  • Mansoor A, Tanaka K and Kamada N (1992) Molecular aspects of Indian patients with myelodysplastic syndrome, chronic myelocytic leukemia and non-Hodgkin’s lymphoma. Proc. Hiroshima Univ. RINNB, 33, 197-209.

  • Mitelman F, Levan G, Nilsson PG and Brandt L (1976) Non-random karyotypic evolution in chronic myeloid leukemia. Int. J. Cancer. 18, 24-30.

  • Mitelman F (1993) The cytogenetic scenario of chronic myeloid leukemia. Leuk. Lymphoma. 11 (Suppl.) 11-15.

  • Nanjangud G, Kadam PR, Saikia T, Bhisey AN, Kumar A, Gopal R, Chopra H, Nair CN and Advani SH (1994) Karyotypic findings as an independent prognostic marker in chronic myeloid leukemia blast crisis. Leuk. Res. 18, 385-392.

  • Nowell PC (1976) The clonal evolution of tumor cell populations. Science. 194, 23-28.

  • Oguma (1980) Cytogenetic analysis of 122 cases of chronic myelocytic leukemias. Acta. Haematol. Jpn. 43, 30-43 (in Japanese).

  • Sadamori N, Matsunaga M, Yao E, Nishino K, Tomonaga Y, Tagawa M, Kusano M and Ichimaru M (1980) Chromosomes in the chronic phase of chronic granulocytic leukemia. Cancer Genet. Cytogenet. 1, 229-310.

  • Sandberg AA (1983) Chromosome in the chronic phase of CML. Vischows Arch. (Cell pathology) 29, 51-55.

  • Sattler M and Griffin JD (2001) Mechanism of transformation by the BCR/ABL oncogene. Int J. Hematol. 73, 278-291.

  • Sasaki M, Kondo K and Tomiyasu T (1983) Cytogenetic characterization of ten cases of Ph1-positive acute myelogenous leukemia. Cancer Genet. Cytogenet. 9, 119-128.

  • Sato Y, Kitano K, Tsunoda S, Yosida M, Kajii E, Suda T, Sakamoto S, Motoyoshi K, Saito M and Miura Y (1988) Karyotype evolution and multilineage involvement of Philadelphia chromosome-positive clones in blastic transformation of two patients with chronic myelocytic leukemia. Blood. 71, 1561-1567.

  • Skorski (2008) BCR/ABL DNA damage and DNA repair: implications for new treatment concepts. Leuk. Lymphoma. 49, 610-614.

  • Sonta S and Sandberg AA (1977) Chromosomes and causation of human cancer and leukemia. Values of detailed chromosome studies on large numbers of cells in CML. Am. J. Hematol. 3,121-126.

  • Swolin B, Weinfeld A, Westin J, Waldensröme J and Magnusson B (1985) Karytypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression. Cancer Genet. Cytogenet. 18, 65-79.

  • Tanaka H, Tanaka K, Oguma N, Ito K, Kyo T, Dohy H and Kimura A (2004) Effects of interferon-alpha on chromosome abnormalities in treated chronic myelogenous leukemia patients. Cancer Genet. Cytogenet. 153, 133-143.

  • Tanaka K, Kamada N, Oguma N, Takimoto Y, Kuramoto A and Ohkita T (1984) Cytogenetic studies on chronic myelocytic leukemia: evolution of clones with additional Ph1 chromosome detected by means of a large number of karyotype analysis. Jpn. J. Clin. Hematol. 25, 1778-1787 (in Japanese).

  • Tanaka K and Kamada N (1986a) Chromosome analysis by computer: current technological status and future progress. Cell Technol. 5,546-556 (in Japanese).

  • Tanaka K and Kamada N (1986b) Automated chromosome analysis. Sci. Forum 9, 517-526 (in Japanese).

  • Tanaka K, Takechi M, Hong J, Shigeta C, Oguma N, Kamada N, Takimoto Y, Kuramoto A, Dohy H and Kyo T (1989) 9;22 translocation and bcr rearengements in chronic myelocytic leukemia patients among atomic bomb survivors. J. Radiat. Res. 30, 352-358.

  • Tanaka K and Kamada N (1990) bcr gene rearrangement and expression in chronic myelocytic leukemia. Acta. Haematol. Jpn. 53, 1559-1568.

  • Tanaka K, Mansoor AM, Shigeta C, Oguma N and Kamada N (1992a) Loss of heterozygosity at D3S2 locus of short arm of chromosome 3 in chronic myelogenous leukemia. Cancer Genet. Cytogenet. 61, 42-45.

  • Tanaka K, Takauchi K, Takechi M, Dohy H and Kamada N (1992b) Chronic myelocytic leukemia with myeloblastoma has higher frequency of RAS oncogene mutation. Leuk. Res. 16, 947.

  • Tanaka K, Hashimoto T, Oguma N, Dohy H and Kamada N (1993) Influence of M-BCR breakpoints with chronic myelocytic leukemia. Cancer Genet. Cytogenet. 70, 39-47.

  • Tanaka K, Arif M, Kyo T, Dohy H and Kamada N (2000) Transposition of duplicated chromosomal segment involving fused BCR-ABL gene or ABL oncogene alone in chronic myelocytic leukemia and Ph chromosome-positive acute leukemia with complex karyotype. Cancer Genet. Cytogenet. 119, 8-14.

  • Tanaka K, Minamihisamatu M, Yagi Sh, Kyo T, Dohy H and Kamada N (2001) Two step mechanism for information of complex 9;22 chromosome translocation in chronic myelocytic leukemia detected by fluorescence in situ hybridization. Exp. Oncology 23, 29-38.

  • Testa JR, Mintz U, Rowley JD, Vardiman JW and Golomb HM (1979) Evolution of karyotypes in acute nonlymphocytic leukemia. Cancer Res. 39, 3619-3627.


Abstract Views: 364

PDF Views: 100




  • Small Percent of Additional Abnormal Clones to Ph Chromosome in the Early Chronic Phase Detected by Large Number of Karyotype Analysis and Transformation to Blastic Crisis in Chronic Myelocytic Leukemia

Abstract Views: 364  |  PDF Views: 100

Authors

Kimio Tanaka
Dept. of Radiobiology, Institute for Environmental Sciences, Hachazawa-2-121, Rokkasho, Takahoko, Kamikita, Aomori-039-3213, Japan
Hiroo Dohy
Hiroshima Red Cross Hospital, Senda Machi-1-9-6, Minami-ku, Hiroshima-730-8619, Japan
Nanao Kamada
Hiroshima Atomic Bomb Relief Foundation-50-1,3 Chome Asakita-ku, Hiroshima 739-1743, Japan

Abstract


Extensive study on Chronic Myelocytic Leukemia (CML) was performed sequentially from the time of early chronic phase to the blastic crisis (BC) phase. A large number of 80-385 metaphases were karyotyped at the time of diagnosis in 16 patients and 13 in BC phase. Three patients were BC phase at diagnosis. All the patients had small percent of clones with additional chromosome aberration in 1.3-12.4% of the observed cells in the early stages of chronic phase. The additional abnormal clones which had existed at the time of diagnosis of early chronic phase remarkably increased in the BC phase of only 5 of 10 patients examined, because 3 of the 13 patients had no additional chromosome aberrations in BC phase. New abnormal clones which were not detected at the time of diagnosis emerged into the BC phase of 5 of the 10 patients. These additional clones were not always associated with the development of the BC. In all 3 patients diagnosed at 10.6 months before developing BC, small sized clone found in early chronic phase related to main clone in BC. Then, detection of additional clones in chronic phase for early detection of BC clone can be useful at only 10.6 months before BC. However, weak correlation between frequency of additional aberrations with Ph chromosome and duration of chronic phase was found. These findings also suggested that leukemic cells harboring Ph chromosome are high chromosome instability, in which are intrinsically labile for the acquisition of various additional chromosome aberrations at any stage, which might be related with resistance to chemotherapy, and therapies of interferon α and imatinib.

Keywords


Chronic Myelocytic Leukemia, Ph Chromosome, Clonal Evolution, Large Amount Karyotype Analysis

References





DOI: https://doi.org/10.17485/ijst%2F2010%2Fv3i3%2F29694